Assessment of a relationship between prognostic biomarkers and treatment response in ISABELA1 &2 IPF cohorts
M. Randall (Basel, Switzerland), S. De Bernard (Lyon, France), I. Seghers (Mechelen, Belgium), N. Verbruggen (Mechelen, Belgium), S. Lim (Foster City, United States), B. Van Den Blink (Mechelen, Belgium), C. Andersen (Mechelen, Belgium), P. Pujuguet (Romainville, France), N. Prasad (Mechelen, Belgium), P. Ford (Mechelen, Belgium), Y. Bauer (Basel, Switzerland)
Source: International Congress 2022 – What is hot in interstitial lung diseases
Session: What is hot in interstitial lung diseases
Session type: Oral Presentation
Number: 1388
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Randall (Basel, Switzerland), S. De Bernard (Lyon, France), I. Seghers (Mechelen, Belgium), N. Verbruggen (Mechelen, Belgium), S. Lim (Foster City, United States), B. Van Den Blink (Mechelen, Belgium), C. Andersen (Mechelen, Belgium), P. Pujuguet (Romainville, France), N. Prasad (Mechelen, Belgium), P. Ford (Mechelen, Belgium), Y. Bauer (Basel, Switzerland). Assessment of a relationship between prognostic biomarkers and treatment response in ISABELA1 &2 IPF cohorts. 1388
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|